The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,164.00
Bid: 12,162.00
Ask: 12,166.00
Change: -82.00 (-0.67%)
Spread: 4.00 (0.033%)
Open: 12,240.00
High: 12,306.00
Low: 12,132.00
Prev. Close: 12,246.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Stocks fall as virus cases rise; U.S. dollar edges higher

Mon, 04th Jan 2021 20:27

* U.S. stocks sharply lower in afternoon trading

* Gold prices rally

* U.S. bond prices fall
(Updates with closing oil prices)

By Caroline Valetkevitch

NEW YORK, Jan 4 (Reuters) - U.S. stocks dropped more than 1%
on Monday, the first trading day of the new year, pulling back
after recent gains to record highs, while the U.S. dollar was up
slightly.

Stocks hit record highs early in the session as investors
focused on the rollout of COVID-19 vaccines, but sentiment
quickly turned cautious over the path of the virus, which
continues to spread amid the discovery of a new variant.

The outcome of runoff elections on Tuesday in Georgia for
two U.S. Senate seats added to the nervousness.

"Investors are feeling a bit nervous on the first trading
day of the new year, and I think this is a confluence of
factors," said Lindsey Bell, chief investment strategist at Ally
Invest, in Charlotte, North Carolina.

MSCI's All-Country World Index, which tracks
stocks across 49 countries, was down 0.7% after earlier hitting
a record high.

The Dow Jones Industrial Average fell 492 points, or
1.61%, to 30,114.48, the S&P 500 lost 64.89 points, or
1.73%, to 3,691.18 and the Nasdaq Composite dropped
210.31 points, or 1.63%, to 12,677.98.

The pan-European STOXX 600 index rose 0.67%, while
Britain's FTSE 100 index closed up 1.7% on its first
post-Brexit trading day.

Britain began vaccinating its population with the COVID-19
shot developed by Oxford University and AstraZeneca on
Monday.

With the lag between a full vaccine rollout and a global
economic recovery, investors will count on central banks to keep
money cheap.

Minutes of the Federal Reserve's Dec. 15-16 policy meeting
are due on Wednesday and should offer more details on
discussions about making the U.S. central bank's forward policy
guidance more explicit and the chance of a further increase in
asset purchases this year.

Friday brings the U.S. employment report for December.

In currencies, the U.S. dollar recovered after falling to
its lowest level since April 2018.

The dollar index rose 0.169%, with the euro up
0.88% to $1.2244.

The Japanese yen strengthened 0.08% versus the greenback to
103.12 per dollar, while Sterling was last trading at
$1.3556, down 0.84% on the day.

Gold prices were up more than 2%, while U.S. crude
futures fell 1.9% to settle at $47.62 a barrel and Brent
futures dropped 1.4% to $51.09.

U.S. Treasury yields edged higher as traders repositioned at
the start of trading in the new year. Benchmark 10-year Treasury
notes last fell 1/32 in price to yield 0.9148%.

(Additional reporting by Ritvik Carvalho in London and by Medha
Singh and Shivani Kumaresan in Bengaluru; Editing by Toby
Chopra, Dan Grebler and Paul Simao)

More News
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 09:41

LONDON BROKER RATINGS: Deutsche Bank starts Deliveroo at 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
12 Feb 2024 09:12

Barclays sees "compelling" entry point at AstraZeneca after recent falls

(Sharecast News) - Barclays has kept an 'overweight' position on AstraZeneca despite the biopharma group's disappointing annual results last week, saying that the stock's recent underperformance provides an attractive entry point for investors.

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
9 Feb 2024 07:51

LONDON BRIEFING: Barclays buys Tesco's retail banking business

(Alliance News) - Stocks in London are called to open higher on Friday, closing off a busy corporate week.

Read more
8 Feb 2024 17:00

LONDON MARKET CLOSE: Softer earnings weigh on underperforming FTSE 100

(Alliance News) - London's FTSE 100 ended lower on Thursday, with mixed corporate updates keeping a lid on enthusiasm, while in New York the S&P 500 has the 5,000 point mark in touching distance.

Read more
8 Feb 2024 14:42

London close: Stocks slip as US jobless claims fall

(Sharecast News) - London markets experienced a downturn in trading on Thursday, with stocks relinquishing earlier gains as investors processed a decrease in jobless claims in the United States.

Read more
8 Feb 2024 12:08

LONDON MARKET MIDDAY: DS Smith surges on takeover approach from Mondi

(Alliance News) - Stock prices in London were mixed at midday Thursday, as markets struggled to find direction amid a mixed wave of corporate updates and earnings.

Read more
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more
2 Feb 2024 06:22

TOP NEWS: US sends drugmakers initial offers in Medicare price talks

(Alliance News) - The US government said it was making initial offers to drugmakers Thursday as part of Medicare negotiations meant to lower the prices many older Americans would pay for 10 medicines.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.